Market revenue in 2023 | USD 8.5 million |
Market revenue in 2030 | USD 13.7 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Total laparoscopic hysterectomy (tlh) |
Fastest growing segment | Laparoscopic Supracervical Hysterectomy (LSH) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Total Laparoscopic Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy |
Key market players worldwide | Johnson & Johnson, The Cooper Companies Inc, B. Braun Medical, Karl Storz, Conmed Corp, RUDOLF Medical, LiNA, Richard Wolf, Utah Medical Products Inc, PURPLE SURGICAL MANUFACTURING LIMITED, Conkin Surgical Instruments, Laborie Medical Technologies, Bissinger, The O.R. Company, LSI Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine manipulation devices market will help companies and investors design strategic landscapes.
Total laparoscopic hysterectomy (tlh) was the largest segment with a revenue share of 38.82% in 2024. Horizon Databook has segmented the India uterine manipulation devices market based on total laparoscopic hysterectomy (tlh), laparoscopic supracervical hysterectomy (lsh), laparoscopically assisted vaginal hysterectomy (lavh), sacrocolpopexy covering the revenue growth of each sub-segment from 2018 to 2030.
The Indian government’s emphasis on reducing healthcare costs and improving patient outcomes has led to an increasing adoption of minimally invasive surgical procedures. Uterine manipulation devices are essential components of these procedures. Healthcare professionals and patients are increasingly recognizing the benefits of uterine manipulation devices, including reduced bleeding, improved visibility, and enhanced accuracy during surgical procedures.
Hence, the adoption of these devices is predicted to surge over the forecast period, driving market growth. Moreover, the Indian government’s initiatives to improve women’s health and reduce maternal mortality rates are expected to accelerate the demand for uterine manipulation devices over the coming decade. In addition, the increasing prevalence of cervical cancer is expected to drive market growth in India.
For instance, according to Human Papillomavirus and Related Cancers Fact Sheet 2023, around 123,907 cases of cervical cancer were diagnosed in 2023, and around 77,348 succumbed to it. Among all HPVrelated cancers, the highest incidence rate was of cervical cancer (18.7%) in 2023. In India, cancer of the cervix uteri is the third most common cancer with an incidence rate of 18.3% (123,907 cases) and the second leading cause of death with a mortality rate of 9.1% as per GLOBOCAN 2020.
Horizon Databook provides a detailed overview of country-level data and insights on the India uterine manipulation devices market , including forecasts for subscribers. This country databook contains high-level insights into India uterine manipulation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account